Answers are grounded in this paper and cite their sources.
The number of new cases of cervical cancer worldwide is likely underestimated due to the lack of cancer registries; however, cervix cancer is the second most common cancer for women worldwide and the first for under-resourced nations and regions, where the majority of deaths occur [1]. It is the biggest cause of years of life lost for women from cancer in the developing world [2]. The development of this cancer requires infection of the cervix with high risk subtypes of the human papilloma virus which is virtually always acquired by sexual exposure. Declines in the rates of cervical cancer have been directly correlated with investment in screening programs for detection of pre-malignant and early cervical cancers, linked to the availability of treatment. In addition, the development of vaccines for the high risk subtypes 16 and 18 offers the opportunity to prevent initial infection by vaccination prior to exposure to these subtypes. Cervical cancer, a major cause of women's morbidity and mortality, is now largely preventable through vaccination for future generations (primary prevention) and screen and treat programs (secondary prevention) to prevent deaths for present generations. Lack of access to the vaccine or screening programs represents a failure to address international development goals and targets related to reproductive health, denying women their fundamental human rights. Girls and women should be an urgent priority investment for governments, and cervical cancer control should be an important part of that agenda. The area of human rights that is directly impacted by cervical cancer prevention (vaccination) and screening [3] includes the right to the highest attainable standard of physical and mental health (Economic Covenant); the obligation on States to take appropriate…budgetary, economic and other measures to the maximum extent of their available resources to ensure that women realize their rights to health care (CEDAW), the prevention of discrimination against women that provides for access to education, and treating adequately those diseases such as cervical cancer that are unique to women (which would relate to education about, and treatment for, cervical disease) and finally, the right to enjoy the benefits of scientific progress and its applications (Economic Covenant), which are all pertinent to the control of cervical cancer. The barriers to screening and vaccination for women need to be addressed for any coordinated program to be successful. Women lack education in regard to their risk and prevention, which hinders their ability to advocate for expansion of vaccination and screening schemes. This is accompanied by a lack of adequate provider and policy maker education not only general information about HPV, but also about use of vaccine, or screening methods available. Providers often face a lack of infrastructure, equipment, supplies, and a national system to support practice. Finally, health professionals may lack counseling experience or comfort with sexually transmitted diseases lessening the chance that HPV infection and vaccination will be addressed with patients. Culture itself can create barriers through cancer phobia, stigma of sexually transmitted disease, cultural taboos (exposing genital area for examination), gender of provider, women putting other family members' health before their own, distrust of “western” medicine, and the use of alternative health providers. In addition, age affects access as in many regions there is an absence of services for adolescents or unmarried women and there is a particular stigma attached to any treatment related to sexually transmitted diseases. Health services to older women are often also not available, resulting in these women (aged 40–55) not being screened despite being at highest risk of pre-malignant and malignant lesions of the cervix. Lack of coverage by health services, and the economic status of women can make it impossible for girls and women to afford vaccination or screening even if services are available. Mixed with mal-distribution of providers and limited transportation, this creates significant barriers to access. Finally, a unique aspect for developing strong prevention and screening programs is the historic lack of intersection between national cancer control programs and vaccination programs that have tended to focus only on pediatrics. The key bridge to resolution of barriers is education of the public, providers, traditional/alternative providers, politicians, and community leaders about the possibility of cervical cancer control and the significant economic and human benefits of investing in this arena. Curriculum content is outlined in Table 1. The obligation to provide access to cervix cancer control services is a national/family/public problem that needs to be embraced and target populations defined. The importance of investment in this urgent area of women's health, by preventing cancer for future generations and eventually reductions in resource consumption with decreases in morbidity and mortality, must be emphasized. The burden of disease hits not only young women but also women who are post-childbearing (45–55) and are at the center of family stability and economy, suggesting that addressing this will have a positive impact on national economies. Progress can be enabled by the establishment of national cancer registries that offer an opportunity to define the problem and map success, and provide a vehicle to improve services. Cancer control programs need a clear intersection with the immunization programs, and a definition of a tandem program for screening focused on the age of highest risk and the most cost effective approach given resource constraints [4]. Inclusion of the goals of vaccination and screening within planned national interval community based health interventions leverage scarce health resources. Success will hinge on the ability to address needed infrastructure for the method chosen, including access to referral and follow up care, as part of the strategic plan. Community engagement that includes men as partners in the initiatives and empowers women to take control of their sexual lives is the basic foundation of addressing barriers to accomplishing the goal of eradication of cervical cancer. This includes addressing the risk to female health associated with the inability to refuse sex or demand the use of condoms, particularly post-treatment which increases risk for other infections as well. For vaccination schemes to be successful, engagement of youth in solutions is required. Beyond the individual, engagement of networks of public/private partnerships, community leaders' advocacy, policy makers, politicians, religious leaders, professional societies and NGOs to create a broad front of support and advocacy for initiatives is needed. This network along with the health professionals will need to explore novel approaches to funding vaccination and screening with international partners. Success in this campaign to eradicate cervical cancer will be defined by: Presence of defined national immunization and screening programs for cervix cancer prevention, Presence of national alliance network to advocate for cervical cancer control, Evidence that young people have been engaged in discussions and plans for roll out of vaccine, % of children/women of target age immunized, % of target population covered by screening program, % of women with abnormal screening receiving follow up treatment, National cancer registry. FIGO calls on member societies to partner with ministries of health and others to develop or improve national vaccination and screening programs for cervical disease based on local resources and geographic issues and work to eliminate barriers to success, including the general knowledge base. FIGO should be a leader in creating a national and international alliance with groups such as IPA, IAAH, WHO, UNFPA, UICC IGCS, and others to address the role of vaccination and screening in eliminating cervical cancer. Ob/Gyn's should use their unique skills and knowledge to assist in public and professional education about the disease. Ob/Gyn's should advocate for youth friendly approaches across disciplines including primary care and pediatrics that also address confidentiality and privacy. FIGO member societies and their constituents should review and modify health professional education curricula to include information on prevention of cervical cancer. FIGO and its member societies should support development of ongoing research into cervical cancer control and assure that all relevant publications are available through the web site.
No takes yet. Share an insight, caveat, or question.
Cain et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: